SCHEMBL19804489

SCHEMBL19804489

C=CC(=O)OCCOc1cc(-c2ccc(-c3ccccc3)cc2CC)ccc1OCCO

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.45
RARA P10276 3/20 0.44
RARB P10826 3/20 0.44
RARG P13631 3/20 0.44
SLC6A9 P48067 5/20 0.40
KDM4E B2RXH2 2/20 0.39
KMT2A Q03164 2/20 0.39
GAA P10253 1/20 0.39
EGFR P00533 1/20 0.39
PDE4A P27815 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4C Q08493 2/20 0.39
PDE4D Q08499 2/20 0.39
PTPN11 Q06124 2/20 0.38
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
ESR1 P03372 1/20 0.36
TSHR P16473 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19558416 0.92 RARA (0.44) THRBRARARARBRARGSLC6A9
SCHEMBL19804108 0.91 THRB (0.44) THRBRARARARBRARGSLC6A9
SCHEMBL19804419 0.90 THRB (0.45) THRBRARARARBRARGSLC6A9
SCHEMBL19804560 0.89 THRB (0.56) THRBSLC6A9KDM4EKMT2AGAA
SCHEMBL19804152 0.89 THRB (0.43) THRBRARARARBRARGSLC6A9
SCHEMBL19804547 0.89 RARA (0.45) THRBRARARARBRARGSLC6A9
SCHEMBL19796751 0.88 THRB (0.44) THRBRARARARBRARGKMT2A
SCHEMBL19804533 0.86 RARB (0.44) RARARARBRARGSLC6A9KDM4E
SCHEMBL17072446 0.84 RARB (0.42) THRBRARARARBRARGALDH1A1
SCHEMBL19804680 0.84 FFAR4 (0.39) THRBRARARARBRARGSLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 THRB 4323/4885RARA 3585/4885RARB 3517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.